<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a correlation between t(2;8) translocation in <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and kappa light chain immunoglobulin production </plain></SENT>
<SENT sid="1" pm="."><plain>Since the kappa chain genes are on chromosome #2, this, as well as data on Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, points to the possibility of position effect on the level of gene action </plain></SENT>
<SENT sid="2" pm="."><plain>Chromosome #2 in the translocation together with chromosome #8 is concerned with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, while the <z:mpath ids='MPATH_458'>normal</z:mpath> homologous chromosome #2 transcribes kappa chains </plain></SENT>
<SENT sid="3" pm="."><plain>This model applies to B cell <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with changes in chromosome #2 which will predictably express kappa chains </plain></SENT>
<SENT sid="4" pm="."><plain>The model also applies to B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> with changes in chromosome #22 which will predictably express lambda chains </plain></SENT>
</text></document>